(Q33701891)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Daniel Velasco-Sánchez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Asuncion Aracil

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Raquel Montero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Ana Mas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Lorenzo Jiménez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Mar O'Callaghan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Antoni Capdevila

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Josep Blanch

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Rafael Artuch

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Mercedes Pineda

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

1-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20865357%20AND%20SRC:MED&resulttype=core&format=json

Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Selective iron chelation in Friedreich ataxia: biologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Friedreich's ataxia: idebenone treatment in early stage patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Friedreich's ataxia: iron chelators that target the mitochondrion as a therapeutic strategy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Inhibition of catechol-O-methyltransferase (COMT) as well as tyrosine and tryptophan hydroxylase by the orally active iron chelator, 1,2-dimethyl-3-hydroxypyridin-4-one (L1, CP20), in rat brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Results of long‐term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Increased iron in the dentate nucleus of patients with Friedrich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Imaging iron stores in the brain using magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

High-field magnetic resonance imaging of brain iron: birth of a biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Monitoring of idebenone treatment in patients with Friedreich's ataxia by high-pressure liquid chromatography with electrochemical detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Clinical experience with high-dose idebenone in Friedreich ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Chemical probes identify a role for histone deacetylase 3 in Friedreich's ataxia gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

How is disease progress in Friedreich's ataxia best measured? A study of four rating scales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Deferiprone targets aconitase: implication for Friedreich's ataxia treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

Mapping of mutation causing Friedreich's ataxia to human chromosome 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-010-0212-7

21 January 2018

1 reference

12 December 2020

Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI

1 reference

12 December 2020

Iron chelation therapy

1 reference

12 December 2020

Marked variation in the cardiomyopathy associated with Friedreich's ataxia

1 reference

12 December 2020

Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin

1 reference

12 December 2020

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome

1 reference

12 December 2020

Safety profile of the oral iron chelator deferiprone: a multicentre study

1 reference

12 December 2020

Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia

1 reference

12 December 2020

10.1007/S12311-010-0212-7

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fycxvxsbrve7dgfvf7rg4uzs5e

30 July 2022

mapped directly with Wikidata item

Dimensions Publication ID

1052809282

0 references

Fatcat ID

release_fycxvxsbrve7dgfvf7rg4uzs5e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fycxvxsbrve7dgfvf7rg4uzs5e

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/fycxvxsbrve7dgfvf7rg4uzs5e

1 reference

30 July 2022